Volume 377, Issue 9777, Pages (May 2011)

Slides:



Advertisements
Similar presentations
Two views of brain function Marcus E. Raichle Trends in Cognitive Sciences Volume 14, Issue 4, Pages (April 2010) DOI: /j.tics
Advertisements

Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)
HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study 
Cautious optimism on public health in post-earthquake Haiti
Figure 1 Inclusion criteria, exclusion criteria, and criteria for virologic failure. CDC, Centers for Disease Control and Prevention; ddC, zalcitabine;
Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort.
Dizziness in older adults
Thank God for Richard Dawkins?
Long-term effects of hormone replacement therapy
Volume 2, Issue 4, Pages e151-e158 (April 2015)
SDC 3: Time until virologic suppression and failure
HIV Prevention and Treatment: The Evolving Role of the Emergency Department  Kristi Stanley, MD, Meredith Lora, MD, Stephen Merjavy, MD, Jennifer Chang,
Brian J Coburn, David J Gerberry, Sally Blower 
Gian Paolo Fadini, Angelo Avogaro  The Lancet Diabetes & Endocrinology 
The Irish health-care system and austerity: sharing the pain
Low-level laser therapy for neck pain
Long-term effects of hormone replacement therapy
Pralidoxime for organophosphate poisoning
Political factors behind US global AIDS programmes slow-down
Klebsiella pneumoniae liver abscesses
Hormones and bones The Lancet Volume 349, Pages S20-S23 (March 1997)
Aspirin in the prevention of cancer – Author's reply
Correction to Lancet Diabetes Endocrinol 2015; 3: 263–74
Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes:
Gene therapy—where are we?
Treatment of Helicobacter pylori in Latin America
Drug-resistant human immunodefiency virus
Constantly high incidence of scarlet fever in Germany
SNPs and coronary heart disease – Authors' reply
Breastfeeding in the 21st century
Volume 382, Issue 9906, Pages (November 2013)
Prevention of HIV spread during the Ebola outbreak in Guinea
Organisation of the care of patients with heart failure
Paediatric mortality related to pandemic influenza A H1N1 infection in England: an observational population-based study  Nabihah Sachedina, MBBS, Prof.
Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz.
HIV myths should not be resuscitated
General Practice Research Database for prescribing analysis
Effect of development assistance on domestic health expenditures
Volume 380, Issue 9849, Pages (October 2012)
HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic.
Volume 4, Issue 10, Pages e433-e441 (October 2017)
Bruce Neal, Fiona Turnbull  The Lancet 
Correction to Lancet Diabetes Endocrinol 2015; 3: 263–74
G. Rocheleau, C.J. Brumme, J. Shoveller, V.D. Lima, P.R. Harrigan 
Volume 375, Issue 9709, Pages (January 2010)
Confessions of a journal junkie
Infant-feeding patterns and HIV-1 transmission
Volume 2, Issue 6, Pages e243-e251 (June 2015)
Volume 371, Issue 9627, Pages (May 2008)
Volume 2, Issue 10, Pages e417-e426 (October 2015)
Telling it like it isn't: truth and lies in a post-9/11 world
Prevention of HIV spread during the Ebola outbreak in Guinea
Thank God for Richard Dawkins?
Low-technology approaches
Thank you to our diverse (but not diverse enough) reviewers
Volume 376, Issue 9734, Pages (July 2010)
Volume 373, Issue 9672, Pages (April 2009)
Vitamin D status and ill health – Author's reply
Arlene Chan, Marc Buyse, Bin Yao  The Lancet Oncology 
Costs of eliminating HIV in South Africa have been underestimated
Children and adolescents with HIV
Liver failure after long-term nucleoside antiretroviral therapy
A remarkable report card on progress in COPD
Difficulties of surgery in the developing world: a personal view
Political factors behind US global AIDS programmes slow-down
Sputum culture conversion in new TB regimens
Jeffrey T Howard, Alexis R Santos-Lozada  The Lancet Planetary Health 
Living in colour—American children, race, and wellbeing
Volume 349, Issue 9062, Pages (May 1997)
Autism, maths, and sex: the special triangle
Presentation transcript:

Volume 377, Issue 9777, Pages 1580-1587 (May 2011) Risk of triple-class virological failure in children with HIV: a retrospective cohort study    The Lancet  Volume 377, Issue 9777, Pages 1580-1587 (May 2011) DOI: 10.1016/S0140-6736(11)60208-0 Copyright © 2011 Elsevier Ltd Terms and Conditions

Figure 1 Inclusion criteria for initial regimens and definition of triple-class virological failure in the main analysis and the comparison of children with adults TCVF=triple-class virological failure. NRTI=nucleoside or nucleotide reverse transcriptase inhibitors. NNRTI=non-NRTI. PI/r=ritonavir-boosted protease inhibitor. PI=protease inhibitor. uPI=unboosted protease inhibitor. The Lancet 2011 377, 1580-1587DOI: (10.1016/S0140-6736(11)60208-0) Copyright © 2011 Elsevier Ltd Terms and Conditions

Figure 2 Incidence per 100 person-years (95% CI) of triple-class virological failure in children with HIV by duration of antiretroviral therapy *At end of year 9. The Lancet 2011 377, 1580-1587DOI: (10.1016/S0140-6736(11)60208-0) Copyright © 2011 Elsevier Ltd Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.